A 39-year-old man with cerebrotendinous xanthomatosis (CTX) had a history of mental retardation (from age 4), cerebellar ataxia and spastic paraparesis (age 33), and cataracts (age 39). The cholestanol level was elevated in the serum (49.6 μg/mL, normal 2.35±0.73 μg/mL). A genetic analysis revealed c.1421G\>A homozygous type in the sterol 27-hydroxylase (*CYP27*) gene ([@B1]). Brain magnetic resonance imaging (MRI) showed cerebral and cerebellar atrophy with signal abnormality around the dentate nucleus and pyramidal tract (arrows [Picture A and B](#g001){ref-type="fig"}; T1-weighted fluid-attenuated recovery sequences). The lesions demonstrated a high signal on T1- and T2-weighted images. Multiple nodular thickening of the nerve roots and trunks of the lumbosacral plexus was detected without gadolinium enhancement on MRI and MR neurography (MRN) (arrowheads [Picture C](#g001){ref-type="fig"}; T2-weighted MRI, [Picture D](#g001){ref-type="fig"}; diffusion-weighted MRN obtained with post-processing with maximum intensity projection). Given that the peripheral nerves are involved in CTX ([@B2]), the CTX diagnosis may be enhanced by the detection of spinal root hypertrophy on MRI.
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